Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 3.840
-0.060 (-1.54%)
Aug 14, 2026, 5:00 PM CET
Genomtec Market Cap
Genomtec has a market cap or net worth of 57.85 million as of August 14, 2026. Its market cap has decreased by -38.24% in one year.
Market Cap
57.85M
Enterprise Value
57.10M
Revenue
30.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
3.84
ChartMarket Cap Chart
Since March 17, 2021, Genomtec's market cap has decreased from 110.55M to 57.85M, a decrease of -47.67%. That is a compound annual growth rate of -11.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 57.85M | 1.05% |
| Dec 30, 2025 | 57.25M | -45.34% |
| Dec 30, 2024 | 104.73M | -21.25% |
| Dec 29, 2023 | 133.00M | 22.23% |
| Dec 30, 2022 | 108.81M | 42.64% |
| Dec 30, 2021 | 76.28M | -31.00% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Synektik Spólka Akcyjna | 3.09B |
| Medinice | 685.35M |
| Medicalgorithmics | 267.23M |
| Milton Essex Spólka Akcyjna | 47.64M |
| Nestmedic | 40.61M |
| InventionMed | 21.39M |
| Adiuvo Investments | 6.19M |
| Zortrax | 880.84K |